Posted by Michael Wonder on 27 May 2022
Medicare premium increase from Alzheimer’s drug to be lowered next year
27 May 2022 - Health and Human Services Secretary Xavier Becerra announced on Friday that Medicare premiums would be adjusted for 2023 following a report that found the cost of including a new Alzheimer’s medication into the program had been overestimated.
“Today, U.S. Department of Health and Human Services Secretary Xavier Becerra announced that Medicare Part B premiums paid by Medicare beneficiaries for 2022 should be adjusted downward to account for an overestimate in costs attributable to the inclusion of new Alzheimer’s drug Aduhelm within the Medicare program for reimbursement,” the Health and Human Service Department said in a statement.
